feed,title,long_url,short_url
ðŸ’°Barrons,Catalent Stock Jumps on $16.5 Billion Sale to Controlling Shareholder of Ozempic Maker Novo Nordisk,https://barrons.com/articles/catalent-stock-novo-nordisk-ozempic-6ba62953?mod=RTA,https://da.gd/TSfKVN
